ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 62 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 62 samples: 13 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional ProgramsCancer research · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE235739_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA987529 and SRA study SRP445807. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 8 samples read as cases, 9 as controls.
How we read this: 13 replicated groups read from 62 sample titles; they account for 41 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7508707 ASPS_Tumor-1_H3K27ac
- GSM7508708 ASPS_Tumor-1_input
- GSM7508709 ASPS_Tumor-2_H3K27ac
- GSM7508710 ASPS_Tumor-2_input
- GSM7508711 ASPS_Tumor-3_H3K27ac
- GSM7508712 ASPS_Tumor-3_input
- GSM7508713 ASPS_Tumor-4_H3K27ac
- GSM7508714 ASPS_Tumor-4_input
- GSM7508715 ASPS_PDX_H3K27ac
- GSM7508716 ASPS_PDX_input
- GSM7508717 ASPS-1_H3K27ac
- GSM7508718 ASPS-1_input
- GSM7508719 ASPS-KY_H3K27ac
- GSM7508720 ASPS-KY_input
- GSM7508721 ASPS-KY_HA
- GSM7508722 FUUR1_H3K27ac
- GSM7508723 FUUR1_input
- GSM7508724 ASPS_PDX_F0 ASPS_PDX_F
- GSM7508725 ASPS_PDX_F4 ASPS_PDX_F
- GSM7508726 ASPS-1
- GSM7508727 ASPS-1_CLX
- GSM7508728 ASPS_Tumor-4 ASPS_Tumo
- GSM7508729 ASPS_Tumor-5 ASPS_Tumo
- GSM7508730 FUUR1
- GSM7508731 ASPS-KY
- GSM7508732 ASPS_Tumor-1 ASPS_Tumo
- GSM7508733 ASPS_Tumor-2 ASPS_Tumo
- GSM7508734 ASPS_Tumor-3 ASPS_Tumo
- GSM7508735 KYdTAG_0h-1 KYdTAG_0h
- GSM7508736 KYdTAG_0h-2 KYdTAG_0h
- GSM7508737 KYdTAG_0h-3 KYdTAG_0h
- GSM7508738 KYdTAG_0h-4 KYdTAG_0h
- GSM7508739 KYdTAG_24h-1 KYdTAG_24h
- GSM7508740 KYdTAG_24h-2 KYdTAG_24h
- GSM7508741 KYdTAG_24h-3 KYdTAG_24h
- GSM7508742 KYdTAG_24h-4 KYdTAG_24h
- GSM7508743 KYdTAG_6h-1 KYdTAG_6h
- GSM7508744 KYdTAG_6h-2 KYdTAG_6h
- GSM7508745 KYdTAG_6h-3 KYdTAG_6h
- GSM7508746 KYdTAG_6h-4 KYdTAG_6h
+ 22 more — browse all 62 samples with per-sample file links →
- GSE286950 PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 16 samples same disease briefing · shares targetable, sarcoma, drives
- GSE303028 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma 104 samples same disease briefing · shares alveolar, sarcoma
- GSE303151 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [CUT&RUN] 50 samples same disease briefing · shares alveolar, sarcoma
- GSE279337 Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma 40 samples same disease briefing · shares targetable, sarcoma
- GSE300974 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [RNA-seq] 30 samples same disease briefing · shares alveolar, sarcoma
- GSE329566 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [ChIP-Seq] 8 samples same disease briefing · shares alveolar, sarcoma
- GSE303149 CDK8 Inhibition Releases the Muscle Differentiation Blockade in Fusion-driven Alveolar Rhabdomyosarcoma [ATAC-seq] 6 samples same disease briefing · shares alveolar, sarcoma
- GSE131309 Opposing genetic and immune mechanisms shape oncogenic programs in synovial sarcoma 4 samples same disease briefing · shares programs, sarcoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.